{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06462781",
            "orgStudyIdInfo": {
                "id": "23-267"
            },
            "organization": {
                "fullName": "The Cooper Health System",
                "class": "OTHER"
            },
            "briefTitle": "Localized Injection of Lidocaine and Glucocorticoid for Headache Treatment",
            "officialTitle": "Intra-Arterial Injection of Lidocaine and Glucocorticoid in the Treatment of Intractable Headaches",
            "acronym": "LIGHT",
            "therapeuticArea": [
                "Neurology"
            ],
            "study": "localized-injection-of-lidocaine-and-glucocorticoid-for-headache-treatment"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2025-03",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-03",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-03",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-06-12",
            "studyFirstSubmitQcDate": "2024-06-12",
            "studyFirstPostDateStruct": {
                "date": "2024-06-17",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-12",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-17",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Daniel A Tonetti, MD",
                "investigatorTitle": "Director, Cerebrovascular Neurosurgery; Director, Acute Stroke and NeuroInterventional Suite",
                "investigatorAffiliation": "The Cooper Health System"
            },
            "leadSponsor": {
                "name": "The Cooper Health System",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this clinical trial is to test whether injecting lidocaine and steroids into two blood vessels of the brain can help treat chronic headaches (migraines).\n\nThe main questions this study aims to answer are:\n\n* Is this treatment safe for chronic migraine patients?\n* Is this treatment effective for chronic migraine patients?\n\nParticipants will:\n\n* Be treated once with lidocaine and steroid infused into the middle meningeal arteries (two blood vessels in the brain).\n* Attend appointments scheduled 1 week, 6 weeks, and 12 weeks after the treatment for a checkup.\n* Keep a log of their symptoms."
        },
        "conditionsModule": {
            "conditions": [
                "Refractory Migraine"
            ],
            "keywords": [
                "headache",
                "migraine",
                "lidocaine",
                "glucocorticoid",
                "middle meningeal artery",
                "intra-arterial",
                "status migrainosus"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 230,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Treatment Cohort",
                    "type": "EXPERIMENTAL",
                    "description": "Intra-arterial 80mg lidocaine and 40mg methylprednisolone",
                    "interventionNames": [
                        "Drug: Lidocaine hydrochloride",
                        "Drug: Methylprednisolone sodium succinate"
                    ]
                },
                {
                    "label": "Observational Cohort",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Continuation of standard therapies",
                    "interventionNames": [
                        "Other: Standard of Care"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Lidocaine hydrochloride",
                    "description": "Intra-arterial injection of 40mg lidocaine per middle meningeal artery (total 2 arteries) administered one time",
                    "armGroupLabels": [
                        "Treatment Cohort"
                    ],
                    "otherNames": [
                        "lidocaine",
                        "Xylocaine-MPF"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Methylprednisolone sodium succinate",
                    "description": "Intra-arterial injection of 20mg methylprednisolone per middle meningeal artery (total 2 arteries) administered one time",
                    "armGroupLabels": [
                        "Treatment Cohort"
                    ],
                    "otherNames": [
                        "methylprednisolone",
                        "SOLU-MEDROL"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Standard of Care",
                    "description": "Acute and/or preventative therapeutic approaches currently used in practice",
                    "armGroupLabels": [
                        "Observational Cohort"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Rate and Duration of Symptomatic Relief",
                    "description": "Change in headache assessment scores (MIDAS, verbal pain scale, numeric pain scale) and patient-reported quantitative and qualitative headache symptoms",
                    "timeFrame": "From screening enrollment to the end of study follow-up at 12 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Number of Participants with Adverse Events",
                    "description": "Reported adverse events classified using MedDRA and CTCAE, including all events, treatment-related events, and any serious adverse event",
                    "timeFrame": "From screening enrollment to the end of study follow-up at 12 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or female greater than or equal to 18 years of age.\n* Documentation of a diagnosis of intractable migraine without aura, including failure of at least four classes of preventative drugs. Either intolerance or side effects requiring discontinuation or adequate trial at therapeutic dose without relief constitutes failure of therapy.\n* Written informed consent obtained from subject and ability for subject to comply with the requirements of the study.\n\nExclusion Criteria:\n\n* Pregnant, breastfeeding, or unwilling to practice contraception during participation in the study. Medically acceptable contraceptives include: (1) surgical sterilization (such as tubal ligation or hysterectomy), (2) approved hormonal contraceptives (such as birth control pills, patches, implants, or injections), (3) barrier methods (such as condom or diaphragm) used with a spermicide, or (4) an intrauterine device (IUD).\n* Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data.\n* Patients with concomitant intracranial pathology (e.g., intracranial malignancy).\n* Blood glucose level on screening complete metabolic blood panel \\&amp;amp;gt; 400 mg/dL.\n* Patients with known hypersensitivity and/or contraindication to either lidocaine hydrochloride or methylprednisolone sodium succinate, including:\n* Patients with known history of hypersensitivity to local anesthetics of the amide type.\n* Patients with systemic fungal infections.\n* Patients with known or suspected hypersensitivity to cow's milk or its components or other dairy products (SOLU-MEDROL\u00ae 40mg presentation includes lactose monohydrate, and may contain trace amounts of milk ingredients).\n* Patients taking chronic medications that, when co-administered with lidocaine and other local anesthetics, are at increased risk of developing methemoglobinemia: nitrates/nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, acetaminophen, metoclopramide, quinine, sulfasalazine.\n* Patients taking chronic medications that, when co-administered with methylprednisolone, are at increased risk for hypokalemia, altered drug levels, convulsions, or altered clearance: amphotericin B, diuretics, aminoglutethimide, macrolide antibiotics, anticholinesterases, antitubercular drugs, cholestyramine, cyclosporine, digitalis glycosides, estrogens (including oral contraceptives), hepatic enzyme inducers/inhibitors, and ketoconazole.\n* Patients have known contraindications for angiography. Patients with contrast allergy will be premedicated with diphenhydramine and steroids.\n* Patient has known active systemic infection or sepsis.\n* Patient has contraindication to anesthetic agents used for conscious sedation/monitored anesthesia care (MAC).\n* Concurrent participation in another research protocol for investigation of an experimental therapy.\n* Known or suspected inability to adhere to study protocol or protocol requirements, as per the discretion of the Investigator or treating provider.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Lynne Kohler",
                    "role": "CONTACT",
                    "phone": "855-306-3876",
                    "email": "kohler-lynne@cooperhealth.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Daniel A Tonetti, MD, MS",
                    "affiliation": "The Cooper Health System",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Cooper University Health Care",
                    "city": "Camden",
                    "state": "New Jersey",
                    "zip": "08103",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Daniel A Tonetti, MD, MS",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Hamza A Shaikh, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Manisha Koneru, MS",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Jane Khalife, MD, MS",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Pratit D Patel, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Ajith J Thomas, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Tudor G Jovin, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Larisa Syrow, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.92595,
                        "lon": -75.11962
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006261",
                    "term": "Headache"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010146",
                    "term": "Pain"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9351",
                    "name": "Headache",
                    "asFound": "Headache",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11852",
                    "name": "Migraine Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M13066",
                    "name": "Pain",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008775",
                    "term": "Methylprednisolone"
                },
                {
                    "id": "D000077555",
                    "term": "Methylprednisolone Acetate"
                },
                {
                    "id": "D000008776",
                    "term": "Methylprednisolone Hemisuccinate"
                },
                {
                    "id": "D000011239",
                    "term": "Prednisolone"
                },
                {
                    "id": "C000009935",
                    "term": "Prednisolone acetate"
                },
                {
                    "id": "D000008012",
                    "term": "Lidocaine"
                },
                {
                    "id": "C000021322",
                    "term": "Prednisolone hemisuccinate"
                },
                {
                    "id": "C000009022",
                    "term": "Prednisolone phosphate"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000779",
                    "term": "Anesthetics, Local"
                },
                {
                    "id": "D000000777",
                    "term": "Anesthetics"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000000889",
                    "term": "Anti-Arrhythmia Agents"
                },
                {
                    "id": "D000061567",
                    "term": "Voltage-Gated Sodium Channel Blockers"
                },
                {
                    "id": "D000026941",
                    "term": "Sodium Channel Blockers"
                },
                {
                    "id": "D000049990",
                    "term": "Membrane Transport Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000893",
                    "term": "Anti-Inflammatory Agents"
                },
                {
                    "id": "D000000932",
                    "term": "Antiemetics"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000005765",
                    "term": "Gastrointestinal Agents"
                },
                {
                    "id": "D000005938",
                    "term": "Glucocorticoids"
                },
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                },
                {
                    "id": "D000018696",
                    "term": "Neuroprotective Agents"
                },
                {
                    "id": "D000020011",
                    "term": "Protective Agents"
                },
                {
                    "id": "D000018931",
                    "term": "Antineoplastic Agents, Hormonal"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11014",
                    "name": "Lidocaine",
                    "asFound": "Self-",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11749",
                    "name": "Methylprednisolone",
                    "asFound": "Fixed",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1833",
                    "name": "Methylprednisolone Acetate",
                    "asFound": "Fixed",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11750",
                    "name": "Methylprednisolone Hemisuccinate",
                    "asFound": "Fixed",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14120",
                    "name": "Prednisolone",
                    "asFound": "Fixed",
                    "relevance": "HIGH"
                },
                {
                    "id": "M229449",
                    "name": "Prednisolone acetate",
                    "asFound": "Fixed",
                    "relevance": "HIGH"
                },
                {
                    "id": "M211887",
                    "name": "Prednisolone hemisuccinate",
                    "asFound": "Fixed",
                    "relevance": "HIGH"
                },
                {
                    "id": "M248881",
                    "name": "Prednisolone phosphate",
                    "asFound": "Fixed",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9047",
                    "name": "Glucocorticoids",
                    "relevance": "LOW"
                },
                {
                    "id": "M4107",
                    "name": "Anesthetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M4109",
                    "name": "Anesthetics, Local",
                    "relevance": "LOW"
                },
                {
                    "id": "M4213",
                    "name": "Anti-Arrhythmia Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M23177",
                    "name": "Sodium Channel Blockers",
                    "relevance": "LOW"
                },
                {
                    "id": "M30025",
                    "name": "Diuretics, Potassium Sparing",
                    "relevance": "LOW"
                },
                {
                    "id": "M4217",
                    "name": "Anti-Inflammatory Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4251",
                    "name": "Antiemetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M8881",
                    "name": "Gastrointestinal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20773",
                    "name": "Neuroprotective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M21869",
                    "name": "Protective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20966",
                    "name": "Antineoplastic Agents, Hormonal",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "AnArAg",
                    "name": "Anti-Arrhythmia Agents"
                },
                {
                    "abbrev": "ChanBlk",
                    "name": "Channel Blockers"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "AnEm",
                    "name": "Antiemetics"
                },
                {
                    "abbrev": "NeuroAg",
                    "name": "Neuroprotective Agents"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                }
            ]
        }
    },
    "hasResults": false
}